Continue to site >
Trending ETFs

Vanguard's Patent About to Expire: What's Next for Active ETFs?

More than 20 years ago, when the ETF industry was still in its adolescence, Vanguard executives had a brilliant idea. Instead of introducing ETFs as independent investment vehicles, they developed and patented a method to incorporate them into mutual funds. That way, investors with short time horizons could buy and sell an ETF share rather than deal with the complexity of a mutual fund share.

After it became clear ETFs were here to stay, some competitors launched ETF versions of their mutual fund strategies. But these clones don’t carry over performance records and also risk cannibalizing higher-fee mutual funds.

Others began converting their mutual funds into ETFs. While this process preserves managers’ track records, it requires shareholder approval and the completion of merger agreements. As a result, they can be a costly and complex endeavor for any asset management firm.

By comparison, introducing an ETF within a mutual fund is straightforward and only requires exemptive relief from the SEC. And it provides a clear advantage to shareholders without necessarily cannibalizing its mutual fund shares. The only problem was Vanguard owned the patent.

But Vanguard’s patent expires in May 2023, and the strategy will soon be open to any asset manager.

See our Active ETFs Channel to learn more about this investment vehicle and its suitability for your portfolio.

A New Alternative?

It’s No Guarantee

The Bottom Line